未登录The Belgian Multidisciplinary Immunotoxicity Board (BITOX): A nationwide initiative of the Belgian Society of Medical Oncology (BSMO)
Verhaert, M.; Aspeslagh, S.; Bechter, O.; Wuyts, S.; Blockx, N.; Brandao, M.; Dekervel, J.; Neyns, B.; Rutten, A.; Seront, E.; Wauters, E.; Schreuer, M. S.; Drowart, A. .png)
分享.png)
收藏Heparin-binding, Hemagglutinin-specific IFN-γ Synthesis at the Site of Infection during Active Tuberculosis in HumansPlace, Sammy; Verscheure, Virginie; de San, Nour; Hougardy, Jean-Michel; Schepers, Kinda; Dirix, Violette; Dediste, Anne; Michel, Olivier; Drowart, Annie; Allard, Sabine D.; Doherty, T. Mark; Lecher, Sophie; Locht, Camille; Mascart, Francoise 分享 收藏 分享 收藏 Methylation-dependent T cell immunity to Mycobacterium tuberculosis heparin-binding hemagglutininTemmerman, S; Pethe, K; Parra, M; Alonso, S; Rouanet, C; Pickett, T; Drowart, A; Debrie, AS; Delogu, G; Menozzi, FD; Sergheraert, C; Brennan, MJ; Mascart, F; Locht, C 分享 收藏 Cross-reactive immune responses against Mycobacterium bovis BCG in mice infected with non-tuberculous mycobacteria belonging to the MAIS-GroupLozes, E; Denis, O; Drowart, A; Jurion, F; Palfliet, K; Vanonckelen, A; DeBruyn, J; DeCock, M; VanVooren, JP; Huygen, K 分享 收藏 Humoral response against heat shock proteins and other mycobacterial antigens after intravesical treatment with bacille Calmette-Guerin (BCG) in patients with superficial bladder cancerZlotta, AR; Drowart, A; Huygen, K; DeBruyn, J; Shekarsarai, H; Decock, M; Pirson, M; Jurion, F; Palfliet, K; Denis, O; Mascart, F; Simon, J; Schulman, CC; VanVooren, JP 分享 收藏 分享 收藏 What are the immunologically active components of Bacille Calmette-Guerin in therapy of superficial bladder cancer?Zlotta, AR; Van Vooren, JP; Denis, O; Drowart, A; Daffé, M; Lefèvre, P; Schandene, L; De Cock, M; De Bruyn, J; Vandenbussche, P; Jurion, F; Palfliet, K; Simon, J; Schulman, CC; Content, J; Huygen, K 分享 收藏 What is the optimal regimen for BCG intravesical therapy? Are six weekly instillations necessary?Zlotta, AR; Van Vooren, JP; Huygen, K; Drowart, A; Decock, M; Pirson, M; Jurion, F; Palfliet, K; Denis, O; Simon, J; Schulman, CC 分享 收藏 分享 收藏 Superficial bladder tumors and increased reactivity against mycobacterial antigens before Bacillus Calmette-Guerin therapyZlotta, AR; Drowart, A; Van Vooren, JP; Shekarsarai, H; De Cock, M; Pirson, M; Palfliet, K; Jurion, F; Simon, J; Schulman, CC; Huygen, K 分享 收藏 Evolution and clinical significance of the T cell proliferative and cytokine response directed against the fibronectin binding antigen 85 complex of bacillus Calmette-Guerin during intravesical treatment of superficial bladder cancerZlotta, AR; Drowart, A; vanVooren, JP; deCock, M; Pirson, M; Palfliet, K; Jurion, F; Vanonckelen, A; Simon, J; Schulman, CC; Huygen, K 分享 收藏 Immunogenicity and protective efficacy of a tuberculosis DNA vaccineHuygen, K; Content, J; Denis, O; Montgomery, DL; Yawman, AM; Deck, RR; DeWitt, CM; Orme, IM; Baldwin, S; DSouza, C; Drowart, A; Lozes, E; Vandenbussche, P; VanVooren, JP; Liu, MA; Ulmer, JB 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
